Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.

A DNA nano-harvester stays on its track inside tumor cells, measuring cancer aggressiveness by detecting a key microRNA ...

Johnson & Johnson (NYSE:JNJ) today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in ...

The teenager was researching the Miura-ori fold when Hurricane Helene made landfall in Florida and wildfires raged in Southern California. “I thought maybe these origami patterns, which are strong and ...

Love new ways to display your favorite photos? Try these charming little origami frames, perfect for displaying small pictures of your family and friends. Man arrested after spraying Ilhan Omar with ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...

Hey there, Bellmore! Let's get started with what's happening in and around town. Read on and stay in the loop. ☕️️ Coming up on the calendar: ... and check out 6 more events on the calendar! Today's ...

Researchers in Sweden created artificial animals that over time develop functioning vision from scratch ...

LEXINGTON, Ky. — Akralos Animal Nutrition, a new North American animal feed and nutrition company, officially launched Feb. 1. Formed through a joint venture between global agriculture leaders ADM and ...

New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...